Reduced T cell-dependent humoral immune response in microsomal prostaglandin E synthase-1 null mice is mediated by nonhematopoietic cells

Journal of Immunology

Volumn 191, Issue 10, 2013, Pages 4979-4988

  Kojima, Fumiaki ^a   Frolov, Andrey ^a   Matnani, Rahul ^a   Woodward, Jerold G ^a   Crofford, Leslie J ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FICOLL; HAPTEN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KEYHOLE LIMPET HEMOCYANIN; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E2; COLLAGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; ISOMERASE; PROSTAGLANDIN E SYNTHASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; GERMINAL CENTER; HEMATOPOIETIC CELL; HUMORAL IMMUNITY; IMMUNOGLOBULIN BLOOD LEVEL; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE; WILD TYPE; ANIMAL; BLOOD; CELL CULTURE; DBA MOUSE; DEFICIENCY; EXPERIMENTAL ARTHRITIS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; COLLAGEN; FEMALE; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-2; INTERLEUKIN-4; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MICE; MICE, INBRED DBA; MICE, KNOCKOUT; T-LYMPHOCYTES;

EID: 84887499506     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301942     Document Type: Article

References (68)

1. Legler, D. F., M. Bruckner, E. Uetz-von Allmen, and P. Krause. 2010. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int. J. Biochem. Cell Biol. 42:198-201.
2. Sugimoto, Y., and S. Narumiya. 2007. Prostaglandin E receptors. J. Biol. Chem. 282:11613-11617.
3. Crofford, L. J. 2001. Prostaglandin biology. Gastroenterol. Clin. North Am. 30:863-876.
4. Rocca, B., and G. A. Fitz Gerald. 2002. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2:603-630.
5. Sakata, D., C. Yao, and S. Narumiya. 2010. Emerging roles of prostanoids in T cell-mediated immunity. IUBMB Life 62:591-596.
6. Kalinski, P. 2012. Regulation of immune responses by prostaglandin E2. J. Immunol. 188:21-28.
7. Hilkens, C. M., H. Vermeulen, R. J. Van Neerven, F. G. Snijdewint, E. A. Wierenga, and M. L. Kapsenberg. 1995. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur. J. Immunol. 25:59-63.
8. Gold, K. N., C. M. Weyand, and J. J. Goronzy. 1994. Modulation of helper T cell function by prostaglandins. Arthritis Rheum. 37:925-933.
9. Yao, C., D. Sakata, Y. Esaki, Y. Li, T. Matsuoka, K. Kuroiwa, Y. Sugimoto, and S. Narumiya. 2009. Prostaglandin E2-EP4 signaling promotes immune inflammation through Th1 cell differentiation and Th17 cell expansion. Nat. Med. 15:633-640.
10. Boniface, K., K. S. Bak-Jensen, Y. Li, W. M. Blumenschein, M. J. McGeachy, T. K. McClanahan, B. S. McKenzie, R. A. Kastelein, D. J. Cua, and R. De Waal Malefyt. 2009. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling. J. Exp. Med. 206:535-548.
11. Jakobsson, P. J., S. Thorén, R. Morgenstern, and B. Samuelsson. 1999. Identification of human prostaglandin E synthase: a microsomal, glutathionedependent, inducible enzyme, constituting a potential novel drug target. Proc. Natl. Acad. Sci. USA 96:7220-7225.
12. Murakami, M., H. Naraba, T. Tanioka, N. Semmyo, Y. Nakatani, F. Kojima, T. Ikeda, M. Fueki, A. Ueno, S. Oh, and I. Kudo. 2000. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275:32783-32792.
13. Trebino, C. E., J. L. Stock, C. P. Gibbons, B. M. Naiman, T. S. Wachtmann, J. P. Umland, K. Pandher, J. M. Lapointe, S. Saha, M. L. Roach, et al. 2003. Impaired inflammatory and pain responses in mice lacking an inducible prostaglandin E synthase. Proc. Natl. Acad. Sci. USA 100:9044-9049.
14. Uematsu, S., M. Matsumoto, K. Takeda, and S. Akira. 2002. Lipopolysaccharidedependent prostaglandin E (2) production is regulated by the glutathione-dependent prostaglandin E (2) synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 168:5811-5816.
15. Kapoor, M., F. Kojima, M. Qian, L. Yang, and L. J. Crofford. 2006. Shunting of prostanoid biosynthesis in microsomal prostaglandin E synthase-1 null embryo fibroblasts: regulatory effects on inducible nitric oxide synthase expression and nitrite synthesis. FASEB J. 20:2387-2389.
16. Kapoor, M., F. Kojima, M. Qian, L. Yang, and L. J. Crofford. 2007. Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway. J. Biol. Chem. 282:5356-5366.
17. Trebino, C. E., J. D. Eskra, T. S. Wachtmann, J. R. Perez, T. J. Carty, and L. P. Audoly. 2005. Redirection of eicosanoid metabolism in mPGES-1-deficient macrophages. J. Biol. Chem. 280:16579-16585.
18. Boulet, L., M. Ouellet, K. P. Bateman, D. Ethier, M. D. Percival, D. Riendeau, J. A. Mancini, and N. Méthot. 2004. Deletion of microsomal prostaglandin E2 (PGE2) synthase-1 reduces inducible and basal PGE2 production and alters the gastric prostanoid profile. J. Biol. Chem. 279:23229-23237.
19. Engblom, D., S. Saha, L. Engström, M. Westman, L. P. Audoly, P. J. Jakobsson, and A. Blomqvist. 2003. Microsomal prostaglandin E synthase-1 is the central switch during immune-induced pyresis. Nat. Neurosci. 6:1137-1138.
20. Mabuchi, T., H. Kojima, T. Abe, K. Takagi, M. Sakurai, Y. Ohmiya, S. Uematsu, S. Akira, K. Watanabe, and S. Ito. 2004. Membrane-associated prostaglandin E synthase-1 is required for neuropathic pain. Neuroreport 15:1395-1398.
21. Kamei, D., K. Yamakawa, Y. Takegoshi, M. Mikami-Nakanishi, Y. Nakatani, S. Oh-Ishi, H. Yasui, Y. Azuma, N. Hirasawa, K. Ohuchi, et al. 2004. Reduced pain hypersensitivity and inflammation in mice lacking microsomal prostaglandin e synthase-1. J. Biol. Chem. 279:33684-33695.
22. Saha, S., L. Engstrom, L. Mackerlova, P. J. Jakobsson, and A. Blomqvist. 2005. Impaired febrile responses to immune challenge in mice deficient in microsomal prostaglandin E synthase-1. Am. J. Physiol Regul. Integr. Comp. Physiol. 288:R1100-R1107.
23. Kubota, K., T. Kubota, D. Kamei, M. Murakami, I. Kudo, T. Aso, and I. Morita. 2005. Change in prostaglandin E synthases (PGESs) in microsomal PGES-1 knockout mice in a preterm delivery model. J. Endocrinol. 187:339-345.
24. Wang, M., A. M. Zukas, Y. Hui, E. Ricciotti, E. Pure, and G. A. Fitz Gerald. 2006. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proc. Natl. Acad. Sci. USA 103:14507-14512.
25. Inada, M., C. Matsumoto, S. Uematsu, S. Akira, and C. Miyaura. 2006. Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J. Immunol. 177:1879-1885.
26. Elander, L., L. Engstrom, J. Ruud, L. Mackerlova, P. J. Jakobsson, D. Engblom, C. Nilsberth, and A. Blomqvist. 2009. Inducible prostaglandin E2 synthesis interacts in a temporally supplementary sequence with constitutive prostaglandinsynthesizing enzymes in creating the hypothalamic-pituitary-adrenal axis response to immune challenge. J. Neurosci. 29:1404-1413.
27. Ikeda-Matsuo, Y., A. Ota, T. Fukada, S. Uematsu, S. Akira, and Y. Sasaki. 2006. Microsomal prostaglandin E synthase-1 is a critical factor of stroke-reperfusion injury. Proc. Natl. Acad. Sci. USA 103:11790-11795.
28. Kojima, F., M. Kapoor, L. Yang, E. L. Fleishaker, M. R. Ward, S. U. Monrad, P. C. Kottangada, C. Q. Pace, J. A. Clark, J. G. Woodward, and L. J. Crofford. 2008. Defective generation of a humoral immune response is associated with a reduced incidence and severity of collagen-induced arthritis in microsomal prostaglandin E synthase-1 null mice. J. Immunol. 180:8361-8368.
29. Kindred, B. 1979. Nude mice in immunology. Prog. Allergy 26:137-238.
30. Slack, J., G. P. Der-Balian, M. Nahm, and J. M. Davie. 1980. Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymusindependent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J. Exp. Med. 151:853-862.
31. Mond, J. J., I. Scher, D. E. Mosier, M. Baese, and W. E. Paul. 1978. T-independent responses in B cell-defective CBA/N mice to Brucella abortus and to trinitrophenyl (TNP) conjugates of Brucella abortus. Eur. J. Immunol. 8:459-463.
32. Press, J. L. 1981. The CBA/N defect defines two classes of T cell-dependent antigens. J. Immunol. 126:1234-1240.
33. Banchereau, J., and F. Rousset. 1992. Human B lymphocytes: phenotype, proliferation, and differentiation. Adv. Immunol. 52:125-262.
34. Galibert, L., N. Burdin, B. De Saint-Vis, P. Garrone, C. Van Kooten, J. Banchereau, and F. Rousset. 1996. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med. 183:77-85.
35. Skibinski, G., A. Skibinska, and K. James. 2001. The role of hepatocyte growth factor and its receptor c-met in interactions between lymphocytes and stromal cells in secondary human lymphoid organs. Immunology 102:506-514.
36. Skibinski, G., A. Skibinska, G. D. Stewart, and K. James. 1998. Enhancement of terminal B lymphocyte differentiation in vitro by fibroblast-like stromal cells from human spleen. Eur. J. Immunol. 28:3940-3948.
37. Golde, W. T, P. Gollobin, and L. L. Rodriguez. 2005. A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Anim. (NY) 34:39-43.
38. Rose, M. L., M. S. Birbeck, V. J. Wallis, J. A. Forrester, and A. J. Davies. 1980. Peanut lectin binding properties of germinal centres of mouse lymphoid tissue. Nature 284:364-366.
39. Bhan, A. K, L. M. Nadler, P. Stashenko, R. T. McCluskey, and S. F. Schlossman. 1981. Stages of B cell differentiation in human lymphoid tissue. J. Exp. Med. 154:737-749.
40. Hardie, D. L., G. D. Johnson, M. Khan, and I. C. MacLennan. 1993. Quantitative analysis of molecules which distinguish functional compartments within germinal centers. Eur. J. Immunol. 23:997-1004.
41. Szomolanyi-Tsuda, E., and R. M. Welsh. 1998. T-cell-independent antiviral antibody responses. Curr. Opin. Immunol. 10:431-435.
42. Yamaki, K., H. Uchida, Y. Harada, R. Yanagisawa, H. Takano, H. Hayashi, Y. Mori, and S. Yoshino. 2003. Effect of the nonsteroidal anti-inflammatory drug indomethacin on Th1 and Th2 immune responses in mice. J. Pharm. Sci. 92:1723-1729.
43. Lupu, A. R., L. Cremer, S. Durbaca, A. Calugaru, A. Herold, F. Kerek, G. Szegli, and D. L. Radu. 2006. COX-2 inhibitors can down-regulate in vivo antibody response against T-dependent antigens. Roum. Arch. Microbiol. Immunol. 65:59-65.
44. Turull, A., and J. Queralt. 2000. Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats. Immunopharmacology 46:71-77.
45. Ryan, E. P., C. M. Malboeuf, M. Bernard, R. C. Rose, and R. P. Phipps. 2006. Cyclooxygenase-2 inhibition attenuates antibody responses against human papillomavirus-like particles. J. Immunol. 177:7811-7819.
46. Myers, L. K., A. H. Kang, A. E. Postlethwaite, E. F. Rosloniec, S. G. Morham, B. V. Shlopov, S. Goorha, and L. R. Ballou. 2000. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum. 43:2687-2693.
47. Monrad, S. U., F. Kojima, M. Kapoor, E. L. Kuan, S. Sarkar, G. J. Randolph, and L. J. Crofford. 2011. Genetic deletion of mPGES-1 abolishes PGE2 production in murine dendritic cells and alters the cytokine profile, but does not affect maturation or migration. Prostaglandins Leukot. Essent. Fatty Acids 84:113-121.
48. Jania, L. A., S. Chandrasekharan, M. G. Backlund, N. A. Foley, J. Snouwaert, I. M. Wang, P. Clark, L. P. Audoly, and B. H. Koller. 2009. Microsomal prostaglandin E synthase-2 is not essential for in vivo prostaglandin. Prostaglandins Other Lipid Mediat. 88 (3-4):73-81.
49. Murakami, M., K. Nakashima, D. Kamei, S. Masuda, Y. Ishikawa, T. Ishii, Y. Ohmiya, K. Watanabe, and I. Kudo. 2003. Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 278:37937-37947.
50. Pablos, J. L., B. Santiago, P. E. Carreira, M. Galindo, and J. J. Gomez-Reino. 1999. Cyclooxygenase-1 and -2 are expressed by human T cells. Clin. Exp. Immunol. 115:86-90.
51. Ryan, E. P., S. J. Pollock, T. I. Murant, S. H. Bernstein, R. E. Felgar, and R. P. Phipps. 2005. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. [Published erratum appears in 2005 J. Immunol. 174(8):5134.] J. Immunol. 174:2619-2626.
52. Bernard, M. P., and R. P. Phipps. 2007. CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin. Immunol. 125:138-148.
53. Tokoyoda, K., A. E. Hauser, T. Nakayama, and A. Radbruch. 2010. Organization of immunological memory by bone marrow stroma. Nat. Rev. Immunol. 10:193-200.
54. Fang, Y., C. Xu, Y. X. Fu, V. M. Holers, and H. Molina. 1998. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160:5273-5279.
55. Humphrey, J. H., D. Grennan, and V. Sundaram. 1984. The origin of follicular dendritic cells in the mouse and the mechanism of trapping of immune complexes on them. Eur. J. Immunol. 14:859-864.
56. Heinen, E., N. Cormann, M. Braun, C. Kinet-Denoël, J. Vanderschelden, and L. J. Simar. 1986. Isolation of follicular dendritic cells from human tonsils and adenoids. VI. Analysis of prostaglandin secretion. Ann. Inst. Pasteur Immunol. 137D: 369-382.
57. Lee, I. Y., W. Cho, J. Kim, C. S. Park, and J. Choe. 2008. Human follicular dendritic cells interact with T cells via expression and regulation of cyclooxygenases and prostaglandin E and I synthases. J. Immunol. 180:1390-1397.
58. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, H. Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167-178.
59. Renshaw, B. R., W. C. Fanslow, III, R. J. Armitage, K. A. Campbell, D. Liggitt, B. Wright, B. L. Davison, and C. R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889-1900.
60. Foy, T. M., D. M. Shepherd, F. H. Durie, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymusdependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567-1575.
61. Durie, F. H., R. A. Fava, T. M. Foy, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261:1328-1330.
62. Gordin, M., M. Tesio, S. Cohen, Y. Gore, F. Lantner, L. Leng, R. Bucala, and I. Shachar. 2010. c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74. J. Immunol. 185:2020-2031.
63. Ohnishi, T., M. Suwa, T. Oyama, N. Arakaki, M. Torii, and Y. Daikuhara. 2000. Prostaglandin E2 predominantly induces production of hepatocyte growth factor/scatter factor in human dental pulp in acute inflammation. J. Dent. Res. 79:748-755.
64. Zhang, L., T. Himi, and S. Murota. 2000. Induction of hepatocyte growth factor (HGF) in rat microglial cells by prostaglandin E (2). J. Neurosci. Res. 62:389-395.
65. Plantier, L., S. Marchand-Adam, J. Marchal-Sommé, G. Lesèche, M. Fournier, M. Dehoux, M. Aubier, and B. Crestani. 2005. Defect of hepatocyte growth factor production by fibroblasts in human pulmonary emphysema. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L641-L647.
66. Shoham, T., R. Parameswaran, Y. Shav-Tal, M. Barda-Saad, and D. Zipori. 2003. The mesenchymal stroma negatively regulates B cell lymphopoiesis through the expression of activin A. Ann. N. Y. Acad. Sci. 996:245-260.
67. Pawelzik, S. C., N. R. Uda, L. Spahiu, C. Jegerschöld, P. Stenberg, H. Hebert, R. Morgenstern, and P. J. Jakobsson. 2010. Identification of key residues determining species differences in inhibitor binding of microsomal prostaglandin E synthase-1. J. Biol. Chem. 285:29254-29261.
68. Xu, D., S. E. Rowland, P. Clark, A. Giroux, B. Côté, S. Guiral, M. Salem, Y. Ducharme, R. W. Friesen, N. Méthot, et al. 2008. MF63 [2-(6-chloro-1H-phenanthro[9, 10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation. J. Pharmacol. Exp. Ther. 326:754-763.